Fibroblast Growth Factor-23 May Serve as a Novel Biomarker for Renal Osteodystrophy Progression

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.2018.3934
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

AKR1C3 Overexpression May Serve as a Promising Biomarker for Prostate Cancer Progression

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2014English

The Biomarker Niche for Fibroblast Growth Factor 23 Testing in CKD

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Inflammation Regulates Fibroblast Growth Factor 23 Production

Current Opinion in Nephrology and Hypertension
Internal MedicineNephrology
2016English

Multiple Faces of Fibroblast Growth Factor-23

Current Opinion in Nephrology and Hypertension
Internal MedicineNephrology
2016English

Serum Fibroblast Growth Factor-23 and Incident Hypertension

Journal of Hypertension
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2016English

Fibroblast Growth Factor 23 and the Last Mile

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2020English

Fibroblast Growth Factor 23 and Inflammation in CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2012English

Basic Fibroblast Growth Factor Expression Is Increased in Human Renal Fibrogenesis and May Mediate Autocrine Fibroblast Proliferation

Kidney International
Nephrology
2000English

Fibroblast Growth Factor 21 as a Circulating Biomarker at Various Stages of Colorectal Carcinogenesis

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy